Read Summary

Helicobacter pylori decreased the efficacy of immune checkpoint inhibitors in mice and was associated with a less efficacious response to therapy in a retrospective study of nonsmall-cell lung cancer patients, researchers say.
Reuters Health Information

Print Friendly, PDF & Email